Clarity, Quality and Efficiency
Unveiled in April 2026, Brenntag's biopharma brand, Byphar, is aimed at companies in the biopharmaceutical industry. Joakim Rehné, President of Brenntag Pharma EMEA, explains the strategy behind the new brand.
Pharma
Hovione Names Stefan Doboczky New CEO
Chairman of the Board of Directors Stefan Doboczky to take over operational leadership of the family-owned pharmaceutical technology and services group on April 1, 2027.
Northway Biotech Opens €61 Million Cell Therapy and Personalized Medicine CDMO
Northway Biotech is significantly expanding its development and manufacturing capacity with a new 3,500 sq. m facility featuring up to 20 independent cGMP manufacturing lines.
Beyond the Catalog: Enamine's Journey to Global Drug Discovery Partner
In 2026, Enamine celebrates 35 years — from a small grant-funded Kyiv lab to a global partner with 3,000+ people across six countries.
Samsung Biologics Launches CHF 1.46 Billion Tender Offer for PolyPeptide
Samsung Biologics has published its formal offer prospectus to acquire PolyPeptide, deepening its push into peptide manufacturing as CDMOs race to expand capacity for GLP-1 and other peptide-based drugs.
Evonik Invests €93 Million in Vancouver GMP Plant to Triple LNP Capacity
New GMP (Good Manufacturing Practice) facility to meet increasing demand for lipid nanoparticle (LNP) development and clinical drug product manufacturing.
Wiley Launches Its First Spectral Analysis API Portfolio
New APIs extend Wiley's gold-standard spectral data and analytical intelligence directly into lab, vendor, and platform workflows.
Hovione Completes €40 Million Expansion of Loures Tablet Manufacturing Center
Expansion strengthens integrated manufacture of amorphous solid dispersions (ASDs) by spray drying and tableting at a single site, accelerating development and simplifying supply.
Piramal Pharma Acquires Yapan Bio
Piramal Pharma strengthens its biologics CDMO business, converting Yapan Bio from associate company to subsidiary and expanding vaccine and biologics manufacturing capabilities.
Cancer Vaccines Get Their First Real Win
The first personalized mRNA cancer therapy to beat the standard of care is now headed for regulators.
Modular Automation Moves from Vision to GMP Reality
A pharma project demonstrates how MTP can accelerate integration while reducing validation effort.
Eurofins CDMO Alphora Expands Capacity and HPAPI Capabilities
Eurofins CDMO Alphora has expanded its kilolab and high-potency active pharmaceutical ingredient (HPAPI) development and manufacturing capabilities in Ontario.
CDMO Live Americas
CDMO Live Americas is where external manufacturing partnerships are made.
Novo Nordisk Partners with Amazon to Boost Drug Discovery
Novo Nordisk and Amazon Web Services (AWS) have partnered to accelerate drug discovery with AI. A co-innovation hub in London will facilitate efforts to reduce the time to market for future medicines.
Beacons of the Start-up Scene, Part 9: Biovox
Biovox develops bioplastic compounds that offer features such as inherent antimicrobial properties. At the same time, they are environmentally friendly.
Cambrex Milan Constructs New $30 Million R&D Facility; Celebrates 80th Anniversary
CDMO Cambrex started construction on a new R&D facility at its Milan, Italy site. The $30 million investment adds advanced analytical development and process R&D capabilities.
Bristol Myers Squibb Invests $2.3 Billion in Houston Campus
The investment furthers the company's $40 billion commitment to invest in American innovation and manufacturing.
Mabion and KriSan Biotech Launch Partnership for Next-Gen ADCs
The partners will combine their unique capabilities to jointly develop, offer, and deliver integrated services in the Antibody-Drug Conjugates (ADC) segment for the global pharmaceutical and biotechnology industries.
Lonza and Engitix Announce License Agreement to Advance Targeted ADC Development
Agreement advances new therapies through Engitix’s unique focus on the extracellular matrix (ECM).
Brenntag Pharma Enters into a Strategic Partnership with Evonik
An exclusive distribution agreement for Evonik Rexim amino acids strengthens Brenntag's role in the biopharma and API markets.
Samsung Biologics to Acquire PolyPeptide in All-Cash Deal, Expanding Global Manufacturing
PolyPeptide's specialized peptide expertise and global multi-site network to strengthen Samsung Biologics' multi-modality and global manufacturing excellence.
How FDA's PreCheck Pilot Aims to Speed Up US Drug Manufacturing
DCAT reports that FDA has selected seven companies for its new PreCheck Pilot Program, designed to encourage US-based drug manufacturing through earlier engagement and a more predictable regulatory path.
Olon Expands Concord, Ohio Site, Doubling US Manufacturing Capacity
Olon has completed a major expansion at its Concord, Ohio facility, doubling production capacity and strengthening the site's role as a US manufacturing hub within its global development network.
Fujifilm Biotechnologies Selected for FDA PreCheck Pilot Program to Advance US Drug Manufacturing
Fujifilm Biotechnologies' Holly Springs, NC facility has been chosen as one of seven participants in the FDA's PreCheck Pilot Program, aimed at strengthening US pharmaceutical manufacturing and regulatory readiness.
Innexis Acquires Novartis's Kundl Site
Innexis plans to acquire the multi-user facility in Kundl, Tyrol, from Novartis.
Evonik Invests $100 Million in US API Production
Evonik is modernizing the API production at its Tippecanoe site in the US Over the next five years, the company will invest $100 million in upgrading key plant components.
Siddharth Mittal Appointed as Managing Director & CEO of Syngene International
Syngene International announced that Siddharth Mittal has assumed the role of Managing Director and Chief Executive Officer of the Company, effective 1 July 2026.
Symeres and Axxam Unite Drug Discovery Platforms Under Single Scientific Chief
Russell Thomas, who has held senior roles at both organisations, takes on the joint CSO position as Symeres and Axxam push to offer clients a single pipeline spanning target screening to IND-ready drug candidates.
Adragos and Towa to Produce 1.5 Billion Tablets a Year
CDMO Adragos Pharma Kawagoe and Towa Pharmaceutical have agreed to a manufacturing partnership that will nearly triple solid-dosage capacity, shoring up Japan's fragile generics supply chain.
Lonza Expands Visp Site to Meet Demand in ADCs
Lonza to expand payload-linker manufacturing capacity in Visp (CH) to support the rapidly growing antibody-drug conjugate (ADC) market.
IMCD Launches State-of-the-Art Pharma & Food Hub in New Jersey
IMCD has opened a new Pharmaceutical Technical Centre and Food & Nutrition Hub in Allendale, NJ — bringing labs, co-creation space, and global expertise together to speed up product development.
Digitalization as a Strategic Lever in R&D
Digital Innovation: a key driver of competitiveness and sustainability across the pharmaceutical industry.
Biopharma Innovation: From Bold Idea to Delivered Product
Biopharma has never lacked ambition. The gap has always been between scientific promise and a product on a shelf. That's exactly where the most consequential innovation is happening now.
Trusted Evidence in the Age of AI
AI in pharma has moved past the hype cycle and into implementation. The organizations that pull ahead won't have the most sophisticated models — they'll have the strongest evidence foundation underneath them.
Digital Twins for the Pharma Supply Chain
The key to effective demand & supply planning in the pharmaceutical industry
